Dawaa Reference

Clinical reference

Ovarian Cyst (Simple, Primary Care)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources7 sources

RCOG Green-top Guideline No. 62: Management of Suspected Ovarian Cysts in Premenopausal Women 2011 · RCOG Green-top Guideline No. 34: Management of Ovarian Cysts in Postmenopausal Women 2016 · NICE CKS: Ovarian cyst 2022 · RCOG Green-top Guideline No. 62: Management of Suspected Ovarian Masses in Premenopausal Women, section 6.1 · Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) · Microgynon 30 (ethinylestradiol 30 mcg + levonorgestrel 150 mcg) SmPC sections 4.2-4.4 (eMC product 1130) · StatPearls: Ibuprofen (NCBI Bookshelf NBK542299)

Verified against5 documents
  • RCOG Green-top Guideline No. 62: Management of Suspected Ovarian Masses in Premenopausal Women, section 6.1
  • Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560)
  • Microgynon 30 (ethinylestradiol 30 mcg + levonorgestrel 150 mcg) SmPC sections 4.2-4.4 (eMC product 1130)
  • Ovarian Cyst - disease-level clinical article (ovarian-cyst-full.txt)
  • MSF Essential Drugs 2024 (ibuprofen oral monograph)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (4)

  • Cysts are often silent, found incidentally on exam or pelvic imaging [cyst]
  • One-sided lower abdominal pain or pressure, sharp or dull, intermittent or constant, is the typical complaint [abdominal pain · lower abdominal pain]
  • Cyst rupture or torsion can cause sudden severe pain with nausea and vomiting [cyst · nausea · vomiting]
  • Irregular cycles and abnormal vaginal bleeding can occur [vaginal bleeding]

Signs — what you find (2)

  • Bimanual palpation assesses the ovary's location, shape, size, firmness, tenderness, and mobility, though findings can be hard to feel
  • Normal Doppler flow does not rule out torsion - it was seen in 27% of confirmed left torsion cases and 61% of right torsion cases

Tests (4)

  • A serum or urine hCG test is done first in premenopausal women to rule out pregnancy
  • CA-125 is raised in 85 percent of epithelial ovarian cancers overall but only half of stage I disease confined to the ovary
  • Benign cysts typically show thin smooth walls with no septations, solid parts, or internal Doppler flow
  • A cyst over 10 cm, complex multilocular appearance, papillary or solid components, thick septa, ascites, or increased Doppler flow should raise suspicion for malignancy

If not this — what else fits (8)

  • Ectopic pregnancy is on the differential for an adnexal mass
  • Pelvic inflammatory disease is on the differential
  • Tubo-ovarian abscess is a benign gynecological differential
  • Endometrioma is a benign gynecological differential
  • Appendicitis is on the nongynecological differential list
  • Diverticulitis is on the nongynecological differential list
  • Nephrolithiasis is on the nongynecological differential list
  • Psoas abscess is on the nongynecological differential list

SourceStatPearls "Ovarian Cyst" - disease-level clinical article

Presentation findings are traced to the source above.

1

CONSERVATIVE MANAGEMENT & PELVIC ULTRASOUND MONITORING (PRIMARY CARE STRATEGY)

1st line
Adult dose and duration

Simple cyst under 50 mm in a premenopausal woman: no follow-up needed - these usually resolve over 2-3 cycles on their own. 50 to 70 mm: yearly ultrasound. Above 70 mm: further imaging or surgical assessment, because a cyst that size is hard to characterise on ultrasound alone. No drug therapy is needed to make a simple cyst resolve - it does that on its own. The entries below are for the pain while it does, and, where functional cysts keep forming, for preventing the next one. - no routine follow-up under 50 mm; yearly from 50 to 70 mm

Paediatric dose

Adolescent simple cysts < 5 cm: observe with pelvic ultrasound over 2-3 cycles under pediatric gynecology consultation.

Dose source

RCOG Green-top Guideline No. 62: Management of Suspected Ovarian Masses in Premenopausal Women, section 6.1

Why

Simple physiological cysts (follicular or corpus luteum) < 5 cm in premenopausal women routinely resolve spontaneously without pharmacological intervention.

Cautions
  • Rescanning a simple cyst under 50 mm is not recommended. It finds nothing, and it keeps a well woman in the system for months.
  • Urgent referral to emergency gynecology if acute severe pelvic pain, vomiting, or peritoneal signs occur (suspected cyst rupture or ovarian torsion).
  • Check CA-125 level and calculate Risk of Malignancy Index (RMI) in postmenopausal women or premenopausal women with complex/solid features.
  • Refer to gynecology if cyst is > 5 cm, persistent > 3 months, complex/multilocular on ultrasound, or symptomatic.
2

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Dose source

Ovarian Cyst - disease-level clinical article (ovarian-cyst-full.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions
  • RED FLAG - Sudden onset of unilateral, moderate-to-severe sharp lower abdominal pain (with or without nausea/vomiting), especially after strenuous activity or intercourse, is a red flag for rupture/hemorrhage or torsion and needs prompt evaluation regardless of cyst size.
  • RED FLAG - Surgical referral is indicated for suspected ovarian torsion, persistent adnexal mass, acute abdominal pain, or suspected malignancy - independent of the size-based follow-up thresholds.
3

ETHINYL ESTRADIOL + LEVONORGESTREL

2nd line

Strength0.03 mg

Formoral.solid

Adult dose and duration

1 tablet (30 mcg ethinylestradiol / 150 mcg levonorgestrel) once daily for 21 days followed by 7 pill-free days for prevention of new functional cyst formation x 3-6 cycles

Paediatric dose

Adolescents post-menarche: 1 tablet daily for cycle regulation/prevention under gynecology supervision.

Dose source

Microgynon 30 (ethinylestradiol 30 mcg + levonorgestrel 150 mcg) SmPC sections 4.2-4.4 (eMC product 1130)

Why

Combined oral contraceptives do not hasten the resolution of existing functional ovarian cysts but prevent new cyst formation in women with recurrent functional cysts.

Cautions
  • Does not treat existing cysts; acts by suppressing ovulation to prevent recurrent functional cysts.
  • Contraindicated in women with history of venous thromboembolism, ischemic heart disease, migraine with aura, severe hypertension, or age > 35 and smoking.
  • The clot risk is highest in the first year on it - and it resets, so restarting after a break of four weeks or more carries that first-year risk again, not the lower steady-state one.
Egyptian brands
Egyptian brandManufacturerIndicative price
MICROCEPT 21 TAB.? strength differsCID0.76 EGP (0.04/unit)
MICRODETTE 3* 21 TAB.? strength differsEL NILE.7.50 EGP (0.36/unit)
NORDETTE 5*21 TAB.? strength differsEL NILE. > PFIZER15.00 EGP (0.71/unit)
MICROGENEST 30/150 MCG 21 TABS.? strength differsACDIMA INTERNATIONAL TRADING23.00 EGP (1.10/unit)
TRIOCEPT 21 TAB. X 6 STRIP (TRIPHASIC)? strength differsCID120.00 EGP (5.71/unit)
4

IBUPROFEN

add-on - not a substitute

Strength400 mg

Formoral.solid

Adult dose and duration

400 mg three times daily PRN with food for mild to moderate pelvic pain associated with functional ovarian cyst x 3-5 days PRN

Paediatric dose

5-10 mg/kg/dose [child max 400 mg]

(5-10 mg/kg per dose every 8 hours as needed, with food. Child over 3 months: 5 to 10 mg/kg 3 to 4 times daily, maximum 30 mg/kg daily. The suspension's own label caps pain-and-fever use lower still, at 20 mg/kg/day. Never exceed 400 mg in a single dose.)

Dose by weight
3kg15-30 mg/dose
4kg20-40 mg/dose
5kg25-50 mg/dose
6kg30-60 mg/dose
7kg35-70 mg/dose
8kg40-80 mg/dose
9kg45-90 mg/dose
10kg50-100 mg/dose
11kg55-110 mg/dose
12kg60-120 mg/dose
13kg65-130 mg/dose
14kg70-140 mg/dose
15kg75-150 mg/dose
16kg80-160 mg/dose
17kg85-170 mg/dose
18kg90-180 mg/dose
19kg95-190 mg/dose
20kg100-200 mg/dose
21kg105-210 mg/dose
22kg110-220 mg/dose
23kg115-230 mg/dose
24kg120-240 mg/dose
25kg125-250 mg/dose
26kg130-260 mg/dose
27kg135-270 mg/dose
28kg140-280 mg/dose
29kg145-290 mg/dose
30kg150-300 mg/dose
31kg155-310 mg/dose
32kg160-320 mg/dose
33kg165-330 mg/dose
34kg170-340 mg/dose
35kg175-350 mg/dose
36kg180-360 mg/dose
37kg185-370 mg/dose
38kg190-380 mg/dose
39kg195-390 mg/dose
40kg200-400 mg/dose
41kg205-400 mg/dose (upper capped)
42kg210-400 mg/dose (upper capped)
43kg215-400 mg/dose (upper capped)
44kg220-400 mg/dose (upper capped)
45kg225-400 mg/dose (upper capped)
46kg230-400 mg/dose (upper capped)
47kg235-400 mg/dose (upper capped)
48kg240-400 mg/dose (upper capped)
49kg245-400 mg/dose (upper capped)
50kg250-400 mg/dose (upper capped)
Dose source

Ibuprofen 100 mg/5 ml SmPC section 4.2 (eMC product 4560) for the adult dose: "The recommended dose is 200 mg-400 mg (10-20 ml), up to three times a day as required... do not take more than 1200 mg (60 ml) in any 24 hour period". That label's paediatric section gives weight bands and a 20 mg/kg/day pain-and-fever ceiling but states no mg/kg per dose, so the paediatric 5 to 10 mg/kg per dose is from MSF Essential Drugs 2024 (ibuprofen oral monograph): "Child over 3 months: 5 to 10 mg/kg 3 to 4 times daily (max. 30 mg/kg daily)".

Why

Ibuprofen is an NSAID added on top of expectant management of the functional ovarian cyst to control the pelvic pain while the cyst is left to resolve on its own; it does not treat the cyst itself.

Cautions
  • Symptomatic relief of mild to moderate pelvic discomfort during cyst regression.
  • Take with food or milk to minimize gastrointestinal upset.
  • Do not mask severe acute pain; re-evaluate for torsion or rupture if pain worsens.
  • The 400 mg per-dose ceiling comes from the reference literature, not from the suspension label - that label's largest paediatric single dose is 200 mg. Below about 40 kg the weight calculation binds first and the ceiling never comes into it.
Egyptian brands
Egyptian brandManufacturerIndicative price
DAJUANOFEN 400 MG 20 F.C. TABS.COPAD PHARMA5.00 EGP (0.25/unit)
FLABU 400MG 10 F.C.TAB.DELTA PHARMA3.75 EGP (0.38/unit)
NOVA-PROFEN 400MG 30 F.C. TABLETSSANOFI12.75 EGP (0.42/unit)
IBUPROFEN 400 MG 10 TAB.SEDICO6.00 EGP (0.60/unit)
MAFO 400 MG 30 F.C.TABSEIPICO42.00 EGP (1.40/unit)
BRUFEN 400 MG 30 TABS.KAHIRA > ABBOTT LABORATORIES78.00 EGP (2.60/unit)
PROFUSOL 400MG 20 S.G CAPS.EUROPEAN EGYPTIAN PHARM. IND.31.00 EGP
ANALGIPROF 400 MG 25 SACHETSEVA PHARMA37.50 EGP
NOVA-PROFEN 100MG/5ML ORAL SUSP. 100ML? strength differs? different route - not oral solidSANOFI2.25 EGP
BRUFEMOL-N SUSP. 60 ML? strength differs? different route - not oral solidARAB DRUG COMPANY (ADCO)4.50 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.